News – Page 555 – Endpoints News

Merck to stop making APIs at Pennsylvania site and cut 300 jobs by 2024

4 years ago

Q&A: In an often-overlooked part of the state, a small Massachusetts CMO has its first FDA approval

4 years ago

Moderna preps for a private, more expensive Covid-19 vaccine market as Biden admin frets over unintentional shift

4 years ago

Sobi closes out 24-year partnership with Pfizer; Belgian Exothera site gets thumbs up from FDA

4 years ago

As rivals stumble, Pfizer boasts of a second 'breakthrough' on PhIII RSV vaccine

4 years ago

Public biotechs raising funds? In this economy? A trio of companies brings $1.5B+ to battered sector after PhIII wins

4 years ago

EQRx links arms with Insilico on that two-letter buzzword (AI); Despite miss in previously treated patients, Ribomic ...

4 years ago

Can Moderna actually make a vaccine for the common cold? (And should it?)

4 years ago

Former FDA vaccines deputy Krause heads down under as Mesoblast tries again on nearly entire pipeline

4 years ago

AstraZeneca’s Imfinzi stumbles in cervical cancer, leaving Merck’s Keytruda dominant

4 years ago

FDA serves up a quick rejection of China-only data with a CRL for Lilly's PD-1

4 years ago

A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the pair's prostate cancer work

4 years ago

Drug discovery specialists at Ligand take their antibody biz public via SPAC, aiming to build $850M company

4 years ago

Celsius aims to cool down inflammation with new investors and more pharma deals

4 years ago

Novartis' radiopharma drug wins approval in tough-to-treat prostate cancer patients

4 years ago

Takeda's rare disease drug's manufacturing and supply woes continue as FDA rejects supplement

4 years ago

Cannes Lions Health jury presidents, including Bayer marketing chief, ready for return of on-site event

4 years ago

AstraZeneca doubles down on digital health in its latest collaboration

4 years ago

Moderna trades US baseball marketing for sumo wrestling ads in Japan

4 years ago

Ex-Pfizer staffers slap back at accusations they stole trade secrets for new Eli Lilly partner

4 years ago

Novartis' Sandoz settles with Novo Nordisk for 2024 launch of third Victoza generic

4 years ago

Blasting Russia’s Ukraine invasion, Roche ships more meds and diagnostics to war-torn country

4 years ago

Amid inspection and recall woes, Aurobindo to shut down NJ site in April

4 years ago

FDA approved? Yes, but quite a few pharmas leave out the messy details on accelerated approval

4 years ago

First page Previous page 552 553 554555556 557 558 Next page Last page